MAZE
Ticker
Maze Therapeutics, Inc.
MAZE · Healthcare · Maze Therapeutics, Inc., a clinical stage biopharmaceutical company, develops small molecule precision medicines for the treatment of kidne…Maze Therapeutics, Inc. (MAZE), in the Healthcare sector, has 35 disclosed filings on Paydirt over the trailing twelve months from 5 corporate insiders: 0 purchases and 35 sales. Filers took a median of 2 days from execution to disclosure, and the most recent trade was executed Sep 4 and filed Sep 8. The most active filer was Harold Bernstein with 14 filings.
Add to watchlistFilings, ttm
35
0 buys · 35 sells
Traders, ttm
5
5 insiders
Volume, ttmiDollar value disclosed in the window
$19.8M
estimated for Congress, as filed for insiders
Median delay
2d
execution to disclosure
Last traded
Sep 4
Filed Sep 8
ADViAverage daily dollar volume
$16.9M
market data
Share price · 12M
$24.67 (+4.2%)
Adjusted for splits and dividends.
Volume by month
Buys $0
Sells $20.2M
Estimated for Congress, as filed for insiders · by filing month · past 24 months
Who filed
HBRecent filings
Harold BernsteinSALE
President, R&D & CMO
$255K9,705 sh × $26.22
Exec Sep 4
Filed Sep 8 · 4:20 PM ET Jason V ColomaSALE Chief Executive Officer $553K
21,134 sh across 2 lots
Exec Sep 2
Filed Sep 4 · 4:24 PM ET Harold BernsteinSALE President, R&D & CMO $252K
9,611 sh across 2 lots
Exec Sep 2
Filed Sep 4 · 4:22 PM ET Harold BernsteinSALE President, R&D & CMO $426K
16,141 sh × $26.36
Exec Sep 1
Filed Sep 3 · 4:24 PM ET Atul DandekarSALE CSBO $207K
7,500 sh × $27.58
Exec Aug 28
Filed Aug 31 · 6:32 PM ET Harold BernsteinSALE President, R&D & CMO $446K
16,142 sh × $27.61
Exec Aug 13
Filed Aug 14 · 4:54 PM ET Jason V ColomaSALE Chief Executive Officer $810K
30,304 sh × $26.71
Exec Aug 3
Filed Aug 5 · 4:08 PM ET Atul DandekarSALE CSBO $194K
7,100 sh × $27.31
Exec Jul 29
Filed Jul 31 · 4:15 PM ET Harold BernsteinSALE President, R&D & CMO $400K
13,409 sh × $29.86
Exec Jul 1
Filed Jul 2 · 4:29 PM ET Jason V ColomaSALE Chief Executive Officer $908K
30,311 sh × $29.95
Exec Jul 1
Filed Jul 2 · 4:28 PM ET Atul DandekarSALE CSBO $210K
7,500 sh × $28.02
Exec Jun 29
Filed Jul 1 · 4:17 PM ET Jason V ColomaSALE Chief Executive Officer $622K
23,865 sh × $26.05
Exec Jun 23
Filed Jun 24 · 5:30 PM ET Harold BernsteinSALE President, R&D & CMO $339K
13,253 sh × $25.57
Exec Jun 1
Filed Jun 3 · 5:30 PM ET Jason V ColomaSALE Chief Executive Officer $160K
6,090 sh × $26.20
Exec Jun 1
Filed Jun 3 · 5:30 PM ET Atul DandekarSALE CSBO $198K
7,500 sh × $26.34
Exec May 29
Filed Jun 2 · 5:30 PM ET Jason V ColomaSALE Chief Executive Officer $783K
30,086 sh across 2 lots
Exec May 22
Filed May 27 · 5:30 PM ET Harold BernsteinSALE President, R&D & CMO $393K
15,000 sh × $26.22
Exec May 14
Filed May 18 · 5:30 PM ET Atul DandekarSALE CSBO $190K
7,500 sh × $25.37
Exec Apr 29
Filed May 1 · 5:30 PM ET Harold BernsteinSALE President, R&D & CMO $433K
14,700 sh across 2 lots
Exec Apr 1
Filed Apr 2 · 5:30 PM ET Atul DandekarSALE CSBO $196K
6,710 sh × $29.26
Exec Mar 30
Filed Apr 1 · 5:30 PM ET Harold BernsteinSALE President, R&D & CMO $736K
15,000 sh across 3 lots
Exec Mar 20
Filed Mar 20 · 5:30 PM ET Harold BernsteinSALE President, R&D & CMO $1.5M
29,652 sh × $50.45
Exec Mar 10
Filed Mar 12 · 5:30 PM ET Amy BachrodtSALE SVP, Finance $168K
3,700 sh × $45.47
Exec Mar 2
Filed Mar 3 · 5:30 PM ET Atul DandekarSALE CSBO $341K
7,500 sh across 2 lots
Exec Feb 27
Filed Mar 3 · 5:30 PM ET Amy BachrodtSALE SVP, Finance $187K
4,064 sh × $46.03
Exec Feb 2
Filed Feb 4 · 5:30 PM ET